newwin
Luciann Nguyen
Settings
← Accounts
biotech

BicycleTx Limited

42
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

BicycleTx Limited

New trial — A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

New trialNCT07450859
42/100
Opportunity
Commercial fit5/25
Clinical timing20/20
Biomarker need0/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5

New phase 2 trial NCT07450859 posted by BicycleTx Limited: "A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)". New trial on a phase 2 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 26 days ago.

ConfidenceHigh · 80%clinical development · translational medicine · clinical operations
Draft outreachReview

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

TrialPhaseTesting language
NCT07450859
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
phase 2
—